MCM
M28 Capital Management Portfolio holdings
AUM
$53.8M
1-Year Est. Return
28.63%
This Fund
S&P 500
1 Year Est. Return
+28.63%
AUM
$53.8M
AUM Growth
-$83.8M
(-61%)
Holding
9
Top Buys
No buys this quarter
Top Sells
| 1 | +$14M | |
| 2 | +$2.18M | |
| 3 | +$1.93M | |
| 4 |
Rocket Pharmaceuticals
RCKT
|
+$695K |
| 5 |
ProQR Therapeutics
PRQR
|
+$688K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.09B
| $33.3M | 61.83% |
4,588,284
-1,076,264
|
|
||
2
Invivyd
IVVD
$336M
| $12M | 22.35% |
9,248,250
|
|
||
3
TG Therapeutics
TGTX
$5.61B
| $2.94M | 5.46% |
88,354
-73,246
|
|
||
4
Arrowhead Research
ARWR
$9.98B
| $2.31M | 4.29% |
36,851
-30,549
|
|
||
|
5
ProQR Therapeutics
PRQR
$155M
| $972K | 1.81% |
599,793
-419,705
|
|
||
6
Fractyl Health
GUTS
$125M
| $850K | 1.58% |
1,856,117
|
|
||
|
7
Rocket Pharmaceuticals
RCKT
$316M
| $755K | 1.4% |
210,871
-174,809
|
|
||
|
SLN
8
Silence Therapeutics
SLN
$301M
| $533K | 0.99% |
101,203
-83,897
|
|
||
9
Curis
CRIS
$19.6M
| $156K | 0.29% |
284,889
-236,170
|
|